Project Launched by VTT Develops Computer Models for Predicting Dietary Effects on Health

VTT is launching an extensive EU project called ETHERPATHS, studying the effects of dietary effects mediated by gut microbiota on lipid metabolism. The aim is to accelerate the development of health-promoting foods. The project develops computer assisted models with which food companies and research institutions, for instance, will be able to predict the effects of foods in the body.

The ETHERPATHS project focuses on the balance of lipid metabolism in the body, the effects of foods in tissues and the role of gut microbiota in these processes. Lipid metabolism disorders are associated with several common health care problems, such as ageing, diabetes and cardiovascular diseases. The balance can be influenced by dietary means. The risk of chronic diseases decreases with a diet containing particularly omega-3 fatty acids and foods that contain fibres and phenol. Therefore, fatty fish, berries, fruits and vegetables may be favourable foods in terms of lipid metabolism balance. The body’s own phospholipids are assumed to mediate the health-promoting effects, but their mechanisms of action are still unknown.

The project develops computer-assisted models that emulate the changes in lipid metabolism brought about by eating fish and vegetable oil, berries, fruits and vegetables. The use of models makes it easier to combine data from animal studies and cell-level data in the interpretation of research data from clinical trials, thus promoting research in the health effects of foods and development of foodstuffs. The results of the project and the tools developed in it will in time also be available to in addition to food companies to companies and research institutions that develop diagnostics of health and disease.

The coordinator of the ETHERPATHS project is VTT's Research Professor Matej Oresic. The total project budget for 2009–2012 is EUR 8 million, of which VTT's share is EUR 2.5 million. The project involves a total of 10 European research institutions and companies.

The project partners are: VTT (Finland), University of Barcelona (Spain), University of Gothenburg (Sweden), University of Cambridge (United Kingdom), Institute for Systems Biology SPb (Russia), Federico II University of Naples (Italy), Noray Bioinformatics S.L.U. (Spain), BioMotif AB (Sweden), Advion Biosciences, Ltd. (United Kingdom) and Nestle Research Center (Switzerland). The project is part of the EU FP7 Cooperation Work Programme: Food, agriculture and fisheries, and biotechnology programme (KBBE-2007-2-2-08).

About VTT Technical Research Centre of Finland
VTT Technical Research Centre of Finland is the biggest contract research organization in Northern Europe. VTT provides high-end technology solutions and innovation services. From its wide knowledge base, VTT can combine different technologies, create new innovations and a substantial range of world-class technologies and applied research services, thus improving its clients' competitiveness and competence. Through its international scientific and technology network, VTT can produce information, upgrade technology knowledge and create business intelligence and value added to its stakeholders. For more information, visit http://www.vtt.fi.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...